| scholarly article | Q13442814 |
| P2093 | author name string | Wei Deng | |
| Eric S Bennett | |||
| Andrew R Ednie | |||
| Jianyong Qi | |||
| P2860 | cites work | Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association | Q22306356 |
| Epidemiology and risk profile of heart failure | Q24630778 | ||
| Aberrant sodium influx causes cardiomyopathy and atrial fibrillation in mice | Q27329882 | ||
| Calcium fluxes involved in control of cardiac myocyte contraction | Q28144050 | ||
| A calcineurin-dependent transcriptional pathway for cardiac hypertrophy | Q28269300 | ||
| R222Q SCN5A mutation is associated with reversible ventricular ectopy and dilated cardiomyopathy | Q28275540 | ||
| SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia | Q28286219 | ||
| Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo | Q28360110 | ||
| Mouse beta-galactoside alpha 2,3-sialyltransferases: comparison of in vitro substrate specificities and tissue specific expression | Q28511031 | ||
| Impaired cardiac hypertrophic response in Calcineurin Abeta -deficient mice | Q28587028 | ||
| Regulation of cardiac hypertrophy by intracellular signalling pathways | Q29615166 | ||
| Glycosylation in cellular mechanisms of health and disease | Q29617310 | ||
| New approaches in small animal echocardiography: imaging the sounds of silence | Q30461404 | ||
| Impaired contractile function and calcium handling in hearts of cardiac-specific calcineurin b1-deficient mice | Q30491332 | ||
| Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure | Q31096652 | ||
| Sialyltransferase ST3Gal-IV operates as a dominant modifier of hemostasis by concealing asialoglycoprotein receptor ligands | Q33343091 | ||
| Regulated and aberrant glycosylation modulate cardiac electrical signaling | Q33492044 | ||
| Calcineurin protects the heart in a murine model of dilated cardiomyopathy | Q33936214 | ||
| Minimally invasive aortic banding in mice: effects of altered cardiomyocyte insulin signaling during pressure overload | Q73372293 | ||
| Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy | Q73665478 | ||
| Calcineurin plays a critical role in the development of pressure overload-induced cardiac hypertrophy | Q74129821 | ||
| Arrhythmia-induced cardiomyopathies: the riddle of the chicken and the egg still unanswered? | Q82508549 | ||
| Arrhythmias and dilated cardiomyopathy common pathogenetic pathways? | Q84148977 | ||
| Calcineurin and cardiac function: is more or less better for the heart? | Q84550806 | ||
| Mutation update for GNE gene variants associated with GNE myopathy. | Q34231117 | ||
| Proteasome functional insufficiency activates the calcineurin-NFAT pathway in cardiomyocytes and promotes maladaptive remodelling of stressed mouse hearts | Q34275603 | ||
| Calcineurin and hypertrophic heart disease: novel insights and remaining questions | Q34581528 | ||
| Calcineurin and cardiac hypertrophy: where have we been? Where are we going? | Q34641729 | ||
| Reduced sialylation impacts ventricular repolarization by modulating specific K+ channel isoforms distinctly | Q35048797 | ||
| Effective glycoanalysis with Maackia amurensis lectins requires a clear understanding of their binding specificities | Q35088831 | ||
| Cardiomyopathy in congenital disorders of glycosylation. | Q35616088 | ||
| Global gene expression profiling of end-stage dilated cardiomyopathy using a human cardiovascular-based cDNA microarray | Q35747980 | ||
| Striking In vivo phenotype of a disease-associated human SCN5A mutation producing minimal changes in vitro | Q35816436 | ||
| Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs | Q35846936 | ||
| Differential sialylation modulates voltage-gated Na+ channel gating throughout the developing myocardium | Q36295618 | ||
| Contribution of sialic acid to the voltage dependence of sodium channel gating. A possible electrostatic mechanism | Q36411907 | ||
| Divergent biophysical defects caused by mutant sodium channels in dilated cardiomyopathy with arrhythmia | Q37019675 | ||
| Characterization of mouse sialyltransferase genes: their evolution and diversity | Q37156202 | ||
| Calcineurin-dependent cardiomyopathy is activated by TRPC in the adult mouse heart | Q37219493 | ||
| Cardiomyopathy in the congenital disorders of glycosylation (CDG): a case of late presentation and literature review. | Q37598110 | ||
| Alcohol abuse and glycoconjugate metabolism | Q38005340 | ||
| Modulation of voltage-gated ion channels by sialylation | Q38116835 | ||
| Differential affinities of Erythrina cristagalli lectin (ECL) toward monosaccharides and polyvalent mammalian structural units | Q38298521 | ||
| Transthoracic echocardiography reference values in juvenile and adult 129/Sv mice. | Q39426928 | ||
| Molecular and clinical characterization of a novel SCN5A mutation associated with atrioventricular block and dilated cardiomyopathy | Q39977115 | ||
| Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex | Q40177208 | ||
| A novel mutation and first report of dilated cardiomyopathy in ALG6-CDG (CDG-Ic): a case report | Q40241808 | ||
| The sialic acid component of the beta1 subunit modulates voltage-gated sodium channel function | Q40524605 | ||
| Statistical Metamodeling and Sequential Design of Computer Experiments to Model Glyco-Altered Gating of Sodium Channels in Cardiac Myocytes | Q40699603 | ||
| A background Ca2+ entry pathway mediated by TRPC1/TRPC4 is critical for development of pathological cardiac remodelling | Q42478234 | ||
| Unusually high concentrations of sialic acids on the surface of vascular endothelia | Q42621411 | ||
| N-glycans modulate K(v)1.5 gating but have no effect on K(v)1.4 gating | Q43229646 | ||
| Isoform-specific effects of sialic acid on voltage-dependent Na+ channel gating: functional sialic acids are localized to the S5-S6 loop of domain I. | Q43875665 | ||
| Contractile reserve: are we beginning to understand it? | Q46056317 | ||
| Expression of the sialyltransferase, ST3Gal4, impacts cardiac voltage-gated sodium channel activity, refractory period and ventricular conduction | Q46133792 | ||
| Variability, heritability and environmental determinants of human plasma N-glycome | Q46227174 | ||
| Gene expression profiles in end-stage human idiopathic dilated cardiomyopathy: altered expression of apoptotic and cytoskeletal genes | Q47284005 | ||
| Calcineurin Abeta gene targeting predisposes the myocardium to acute ischemia-induced apoptosis and dysfunction | Q47387424 | ||
| Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases | Q48689994 | ||
| Isoform-specific effects of the beta2 subunit on voltage-gated sodium channel gating. | Q51805811 | ||
| Expanding spectrum of congenital disorder of glycosylation Ig (CDG-Ig): sibs with a unique skeletal dysplasia, hypogammaglobulinemia, cardiomyopathy, genital malformations, and early lethality. | Q51985773 | ||
| SCN5A mutations associate with arrhythmic dilated cardiomyopathy and commonly localize to the voltage-sensing mechanism. | Q52611240 | ||
| Role of sodium channel deglycosylation in the genesis of cardiac arrhythmias in heart failure. | Q53894333 | ||
| Cardiac sodium channel Nav1.5 is regulated by a multiprotein complex composed of syntrophins and dystrophin. | Q54591285 | ||
| α2,3-Sialyltransferase-IV is essential for L-selectin ligand function in inflammation | Q57445739 | ||
| Lectin histochemistry of microvascular endothelium in chick and quail musculature | Q61550640 | ||
| P433 | issue | 5 | |
| P921 | main subject | dilated cardiomyopathy | Q283656 |
| P304 | page(s) | 57 | |
| P577 | publication date | 2016-08-09 | |
| P1433 | published in | Basic Research in Cardiology | Q2453360 |
| P1476 | title | Aberrant sialylation causes dilated cardiomyopathy and stress-induced heart failure | |
| P478 | volume | 111 |
| Q99717148 | Neuraminidase-1 promotes heart failure after ischemia/reperfusion injury by affecting cardiomyocytes and invading monocytes/macrophages |
| Q91885085 | Reduced hybrid/complex N-glycosylation disrupts cardiac electrical signaling and calcium handling in a model of dilated cardiomyopathy |
| Q57124944 | Reduced myocyte complex N-glycosylation causes dilated cardiomyopathy |
Search more.